市場調查報告書
商品編碼
1119136
全球 CBD 石油和 CBD 消費者健康市場規模研究,按產品(CBD 石油,CBD 消費者健康),按分銷渠道(零售,在線,藥房),按地區預測 2022-2028Global CBD Oil & CBD Consumer Health Market Size study, by Product (CBD Oil, CBD Consumer Health), By Distribution Channel (Retail Stores, Online, Pharmacies) and Regional Forecasts 2022-2028 |
2021 年全球 CBD 石油和 CBD 消費者健康市場價值約 313.8 億美元,預計在 2022-2028 年的預測期內以超過 25.60% 的健康增長率增長。
市場增長的一個主要驅動力是大麻二酚 (CBD) 和用於各種藥用和保健目的的輸液產品的接受度不斷提高。此外,有利的政府政策以及由於其健康益處而增加的消費者對大麻二酚的了解和需求正在推動其被接受。此外,CBD 消費者保健產品因其健康益處和缺乏精神作用而廣受歡迎。對含大麻二酚產品的健康益處的日益認識增加了渴望購買這些產品的消費者數量。此外,膳食補充劑、止痛藥、消耗品、局部用藥、油和膠囊等消費品替代品的增加正在推動該行業的發展。公眾對大麻二酚 (CBD) 提供的許多健康益處以及大麻二酚油和注入物品的合法性的了解不斷增加,正在推動 CBD 作為消費者保健產品的採用並推動市場增長。此外,消費者對基於大麻的大麻二酚產品的態度和看法的變化預計將在整個預測期內促進收入增長。消費者對大麻二酚產品的需求不斷增長,包括大麻油、飲料、化妝品和護膚品、膠囊、軟糖和狗零食,可能會推動全球 CBD 油和 CBD 消費者健康市場。大麻二酚通過多種方式進入人體,包括進食、吸煙、吸電子煙和皮膚接觸。在大麻合法的地方,它用於製備藥品和個人護理產品,鼓勵業務增長。 CBD 保健品行業日益激烈的競爭給公司帶來了推出新產品和擴大地域範圍的壓力。例如,Aphria Inc. 於 2019 年 4 月進入德國市場,推出了 CannRelief,這是該公司首個基於大麻二酚的膳食補充劑系列。澳大利亞生物製藥公司 MGC Pharmaceuticals 於 2019 年 4 月與中國電子商務平台 YuShop Global 合作,進入中國 CBD 保健品市場。這種競爭的加強有望成為市場擴張的動力。然而,草藥營養補充劑等替代品的供應將在 2022-2028 年的整個預測期內抑制市場增長。
全球 CBD 石油和 CBD 消費者健康市場研究考慮的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 CBD 石油市場由北美主導。推動市場擴張的主要因素是對 CBD 石油的認識不斷提高、有利的立法、客戶需求的增加以及生產商數量的增加。該地區藥用大麻的合法化,尤其是在美國,也促進了 CBD 石油和 CBD 消費者健康市場的興起。此外,與當地生產商的合作簡化了許多組織的供應鏈管理。他們必須提供符合聯邦和州法規的優質大麻。
本報告中包括的主要市場參與者是:
CVS 科學公司
醫用大麻公司
夏洛特·韋伯
恩多卡
異地二醇
艾力辛醇
新葉天然有限責任公司
歡樂有機
和美
瓊斯勳爵
極光大麻
本研究的目的是確定近年來各個細分市場和國家/地區的市場規模,並預測未來 8 年的價值。該報告旨在包括所涵蓋的每個地區和國家的行業的定性和定量方面。此外,它還提供了有關關鍵方面的詳細信息,例如定義市場未來增長的驅動因素和挑戰。此外,報告還應詳細分析主要參與者的競爭格局和產品供應,以及微觀市場中可供利益相關者投資的機會。市場的詳細細分和子細分如下所述。
按產品
CBD油
CBD 消費者健康
按分銷渠道:
零售商
在線
藥房
按地區
北美
美國
加拿大
歐洲
英國
德國
法國
西班牙
意大利
其他歐洲
亞太地區
中國
印度
日本
澳大利亞
韓國
其他亞太地區
拉丁美洲
巴西
墨西哥
世界其他地方
此外,本研究考慮的年份是:
實際年份 - 2018 年、2019 年、2020 年
2021 年基準年
預測期 - 2022 年 至 2028 年
本報告的目標受眾是全球 CBD 石油和 CBD 消費者健康市場。
主要諮詢公司和顧問
大公司、中型公司、中小企業
風險投資
增值經銷商 (VAR)
第三方知識提供者
投資銀行家
投資者
Global CBD Oil & CBD Consumer Health Market is valued approximately USD 31.38 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 25.60% over the forecast period 2022-2028. The primary factor driving market expansion is the increase in acceptance of cannabidiol (CBD) and infused products for different medicinal and wellness objectives. Furthermore, favourable government policies, as well as increased consumer knowledge and demand for cannabidiol due to its health advantages, are driving its acceptance. Furthermore, CBD consumer health products are gaining popularity due to their health advantages and lack of psychotropic effects. The growing understanding of the health advantages provided by cannabidiol-infused goods has increased the number of consumers eager to purchase these items. Furthermore, the industry is being driven by an increase in consumer product alternatives such as nutritional supplements, analgesics, consumables, topicals, oils, and capsules. The increased public knowledge of the many health advantages afforded by cannabidiol (CBD), as well as the legality of cannabidiol oil and infused items, are driving CBD's adoption as a consumer health product, resulting in market growth. Additioanally, the shift in consumer attitudes and perceptions toward hemp-derived cannabidiol-based products is likely to increase revenue growth throughout the forecast period. The increased consumer demand for cannabidiol-infused goods such as cannabis oil, beverages, cosmetics and skincare items, capsules, gummies, and dog treats are likely to boost the global CBD Oil And CBD Consumer Health Market. Cannabidiol enters the body via several methods, including eating, smoking, vaping, and skin contact. In places where cannabis is legal, it is being utilized to prepare pharmaceuticals and personal care goods, encouraging business growth. Growing competition in the CBD nutraceuticals industry is putting pressure on firms to introduce new products and expand geographically. Aphria Inc., for example, entered the German market in April 2019 by introducing CannRelief, the company's first cannabidiol-based nutraceuticals product line. MGC Pharmaceuticals, an Australian biopharmaceutical company, partnered with the Chinese e-commerce platform YuShop Global in April 2019 to seek entrance into the Chinese CBD nutraceuticals market. Such increased rivalry is expected to drive market expansion. However, the availability of alternatives such as herbal nutraceuticals stifles market growth throughout the projection period of 2022-2028.
The key regions considered for the Global CBD Oil & CBD Consumer Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The CBD oil market was controlled by North America. The primary drivers driving market expansion include rising CBD oil awareness, favourable laws, increased customer desire, and an increase in the number of producers. The legalisation of medicinal cannabis in the area, particularly in the United States, is also contributing to the rise of the CBD oil and CBD consumer health markets. Furthermore, because of partnerships with local producers, many organisations' supply chain management is simplified. They must provide high-quality cannabis in line with federal and state rules.
Major market player included in this report are:
CVSciences, Inc.
Medical Marijuana, Inc.
CHARLOTTE'S WEB
ENDOCA
Isodiol
Elixinol
NuLeaf Naturals, LLC
JOY Organics
Kazmira
Lord Jones
Aurora Cannabis
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
CBD Oil
CBD Consumer Health
By Distribution Channel:
Retail Stores
Online
Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global CBD Oil & CBD Consumer Health Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures